News and innovations published by German exhibitorsback to overview
Today gene therapy and virus production are increasingly becoming the focus of research - also due to the current global situation.
Xell is involved in the field of research for gene therapy applications. Several test series are planned to optimise e.g., the production processes of AAVs and lentiviruses and to improve product titer. Last year, after intensive research, Xell launched HEK ViP NB and HEK ViP NX, two suspension cell culture media with different nutrient contents, which are specifically optimised for virus production. Upscaling can also be performed easily using these media.
In our state-of-the-art S1 and S2 laboratories, we are happy to support our customers' projects and work on further innovations in the field of gene therapy and virus production as well as corresponding analytical services.
Exhibitor: Xell AG